Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 10467 | 23.86 |
09:34 ET | 2406 | 23.99 |
09:36 ET | 4508 | 23.83 |
09:38 ET | 3561 | 23.75 |
09:39 ET | 300 | 23.69 |
09:41 ET | 4206 | 23.74 |
09:43 ET | 5269 | 23.67 |
09:45 ET | 4939 | 23.635 |
09:48 ET | 800 | 23.64 |
09:50 ET | 5649 | 23.73 |
09:52 ET | 4577 | 23.75 |
09:54 ET | 7002 | 23.76 |
09:56 ET | 400 | 23.765 |
09:57 ET | 3326 | 23.87 |
09:59 ET | 3142 | 23.87 |
10:01 ET | 10656 | 23.88 |
10:03 ET | 7413 | 23.78 |
10:06 ET | 3422 | 23.805 |
10:08 ET | 3993 | 23.765 |
10:10 ET | 7511 | 23.81 |
10:12 ET | 839 | 23.87 |
10:14 ET | 1790 | 23.94 |
10:15 ET | 3168 | 23.91 |
10:17 ET | 1478 | 23.91 |
10:19 ET | 3160 | 23.92 |
10:21 ET | 12562 | 23.83 |
10:24 ET | 2844 | 23.84 |
10:26 ET | 2485 | 23.76 |
10:28 ET | 3274 | 23.78 |
10:30 ET | 3181 | 23.72 |
10:32 ET | 1068 | 23.715 |
10:33 ET | 9073 | 23.75 |
10:35 ET | 8262 | 23.76 |
10:37 ET | 4048 | 23.72 |
10:39 ET | 1330 | 23.72 |
10:42 ET | 2848 | 23.72 |
10:44 ET | 7759 | 23.76 |
10:46 ET | 400 | 23.77 |
10:48 ET | 3787 | 23.79 |
10:50 ET | 511 | 23.76 |
10:51 ET | 4518 | 23.795 |
10:53 ET | 1400 | 23.81 |
10:55 ET | 12580 | 23.83 |
10:57 ET | 2319 | 23.86 |
11:00 ET | 1000 | 23.89 |
11:02 ET | 5344 | 23.89 |
11:04 ET | 1605 | 23.89 |
11:06 ET | 2100 | 23.895 |
11:08 ET | 2670 | 23.89 |
11:09 ET | 2253 | 23.88 |
11:11 ET | 900 | 23.89 |
11:13 ET | 2289 | 23.87 |
11:15 ET | 450 | 23.87 |
11:18 ET | 3766 | 23.88 |
11:20 ET | 1350 | 23.9 |
11:22 ET | 550 | 23.91 |
11:24 ET | 3550 | 23.895 |
11:26 ET | 2153 | 23.939 |
11:27 ET | 1402 | 23.94 |
11:29 ET | 2499 | 23.92 |
11:31 ET | 2241 | 23.97 |
11:33 ET | 2269 | 23.96 |
11:36 ET | 600 | 23.96 |
11:38 ET | 2100 | 23.95 |
11:40 ET | 3600 | 23.99 |
11:42 ET | 4928 | 24.03 |
11:44 ET | 1588 | 24.04 |
11:45 ET | 100 | 24.035 |
11:47 ET | 5119 | 24.055 |
11:49 ET | 1440 | 24.04 |
11:51 ET | 6626 | 24.085 |
11:54 ET | 2400 | 24.09 |
11:56 ET | 9730 | 24.08 |
11:58 ET | 1910 | 24.06 |
12:00 ET | 1155 | 24.08 |
12:02 ET | 3910 | 24.13 |
12:03 ET | 1800 | 24.105 |
12:05 ET | 500 | 24.12 |
12:07 ET | 3451 | 24.08 |
12:09 ET | 1655 | 24.0899 |
12:12 ET | 5321 | 24.115 |
12:14 ET | 530 | 24.1157 |
12:16 ET | 545 | 24.0997 |
12:18 ET | 4476 | 24.13 |
12:20 ET | 5232 | 24.125 |
12:21 ET | 805 | 24.08 |
12:23 ET | 2192 | 24.095 |
12:25 ET | 4741 | 24.13 |
12:27 ET | 825 | 24.14 |
12:30 ET | 2901 | 24.12 |
12:32 ET | 3355 | 24.155 |
12:34 ET | 2040 | 24.1599 |
12:36 ET | 1943 | 24.1304 |
12:38 ET | 1590 | 24.1255 |
12:39 ET | 2786 | 24.13 |
12:41 ET | 5174 | 24.14 |
12:43 ET | 3854 | 24.18 |
12:45 ET | 3202 | 24.19 |
12:48 ET | 2384 | 24.2025 |
12:50 ET | 1700 | 24.21 |
12:52 ET | 994 | 24.2 |
12:54 ET | 4680 | 24.18 |
12:56 ET | 26311 | 24.162 |
12:57 ET | 15291 | 24.17 |
12:59 ET | 800 | 24.14 |
01:01 ET | 1600 | 24.13 |
01:03 ET | 1000 | 24.14 |
01:06 ET | 5556 | 24.18 |
01:08 ET | 1500 | 24.18 |
01:10 ET | 300 | 24.19 |
01:12 ET | 3650 | 24.17 |
01:14 ET | 200 | 24.16 |
01:15 ET | 2150 | 24.13 |
01:17 ET | 850 | 24.11 |
01:19 ET | 3615 | 24.125 |
01:21 ET | 2398 | 24.09 |
01:24 ET | 2503 | 24.12 |
01:26 ET | 400 | 24.13 |
01:28 ET | 2412 | 24.13 |
01:30 ET | 700 | 24.13 |
01:32 ET | 2000 | 24.11 |
01:33 ET | 1500 | 24.114 |
01:35 ET | 700 | 24.1 |
01:37 ET | 400 | 24.1 |
01:39 ET | 500 | 24.12 |
01:42 ET | 4605 | 24.08 |
01:44 ET | 400 | 24.08 |
01:46 ET | 2822 | 24.075 |
01:48 ET | 1304 | 24.065 |
01:50 ET | 400 | 24.065 |
01:51 ET | 100 | 24.06 |
01:53 ET | 300 | 24.06 |
01:55 ET | 2025 | 24.07 |
01:57 ET | 5397 | 24.06 |
02:00 ET | 1555 | 24.06 |
02:02 ET | 1305 | 24.06 |
02:04 ET | 2889 | 24.075 |
02:06 ET | 1945 | 24.075 |
02:08 ET | 2264 | 24.09 |
02:09 ET | 4517 | 24.1 |
02:11 ET | 4015 | 24.09 |
02:13 ET | 980 | 24.11 |
02:15 ET | 8153 | 24.17 |
02:18 ET | 2087 | 24.145 |
02:20 ET | 2473 | 24.145 |
02:22 ET | 900 | 24.15 |
02:24 ET | 2201 | 24.17 |
02:26 ET | 1200 | 24.17 |
02:27 ET | 5018 | 24.145 |
02:29 ET | 4205 | 24.145 |
02:31 ET | 2266 | 24.13 |
02:33 ET | 4044 | 24.1 |
02:36 ET | 3726 | 24.12 |
02:38 ET | 1350 | 24.115 |
02:40 ET | 3471 | 24.11 |
02:42 ET | 1264 | 24.08 |
02:44 ET | 2050 | 24.11 |
02:45 ET | 1606 | 24.105 |
02:47 ET | 4448 | 24.115 |
02:49 ET | 2419 | 24.115 |
02:51 ET | 2381 | 24.1 |
02:54 ET | 5683 | 24.1 |
02:56 ET | 4487 | 24.0599 |
02:58 ET | 1026 | 24.02 |
03:00 ET | 4371 | 24.04 |
03:02 ET | 1214 | 24.03 |
03:03 ET | 55001 | 24.08 |
03:05 ET | 5530 | 24.11 |
03:07 ET | 2600 | 24.11 |
03:09 ET | 4119 | 24.1 |
03:12 ET | 48786 | 24.19 |
03:14 ET | 4056 | 24.15 |
03:16 ET | 3842 | 24.15 |
03:18 ET | 1915 | 24.13 |
03:20 ET | 6111 | 24.18 |
03:21 ET | 6742 | 24.17 |
03:23 ET | 3625 | 24.16 |
03:25 ET | 5472 | 24.17 |
03:27 ET | 1111 | 24.17 |
03:30 ET | 1800 | 24.16 |
03:32 ET | 5241 | 24.11 |
03:34 ET | 10633 | 24.14 |
03:36 ET | 1950 | 24.135 |
03:38 ET | 9127 | 24.155 |
03:39 ET | 9120 | 24.2 |
03:41 ET | 13610 | 24.22 |
03:43 ET | 12118 | 24.225 |
03:45 ET | 9427 | 24.225 |
03:48 ET | 6463 | 24.25 |
03:50 ET | 8716 | 24.185 |
03:52 ET | 16016 | 24.215 |
03:54 ET | 20075 | 24.245 |
03:56 ET | 45630 | 24.225 |
03:57 ET | 30816 | 24.215 |
03:59 ET | 117346 | 24.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.0B | 6.9x | --- |
Exelixis Inc | 6.3B | 34.0x | -21.77% |
PTC Therapeutics Inc | 2.8B | -4.9x | --- |
Novavax Inc | 2.1B | -6.6x | --- |
P3 Health Partners Inc | 158.7M | -1.0x | --- |
Halozyme Therapeutics Inc | 5.6B | 18.9x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.9x |
Price/Sales (TTM) | 2.3 |
Price/Cash Flow (TTM) | 6.0x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.